These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 16771934)

  • 21. Glycemic index, carbohydrate and fiber intakes and risk of reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma.
    Mulholland HG; Cantwell MM; Anderson LA; Johnston BT; Watson RG; Murphy SJ; Ferguson HR; McGuigan J; Reynolds JV; Comber H; Murray LJ
    Cancer Causes Control; 2009 Apr; 20(3):279-88. PubMed ID: 18839322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-grade dysplasia in Barrett's esophagus: overdiagnosed and underestimated.
    Curvers WL; ten Kate FJ; Krishnadath KK; Visser M; Elzer B; Baak LC; Bohmer C; Mallant-Hent RC; van Oijen A; Naber AH; Scholten P; Busch OR; Blaauwgeers HG; Meijer GA; Bergman JJ
    Am J Gastroenterol; 2010 Jul; 105(7):1523-30. PubMed ID: 20461069
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IL-1 RN polymorphism is not associated with Barrett's esophagus and esophageal adenocarcinoma.
    Moons LM; Siersema PD; Kuipers EJ; van Vliet AH; Kusters JG
    Am J Gastroenterol; 2005 Dec; 100(12):2818. PubMed ID: 16393246
    [No Abstract]   [Full Text] [Related]  

  • 24. Management of Barrett's esophagus: cases and questions.
    Bresalier R
    Semin Oncol; 2005 Dec; 32(6 Suppl 9):S2-5. PubMed ID: 16399421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Esophageal adenocarcinoma and Barrett's esophagus.
    Sayana H; Wani S; Sharma P
    Minerva Gastroenterol Dietol; 2007 Jun; 53(2):157-69. PubMed ID: 17557044
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiology of Barrett's Esophagus and Esophageal Carcinoma.
    Fabian T; Leung A
    Surg Clin North Am; 2021 Jun; 101(3):381-389. PubMed ID: 34048759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and endoscopic factors predict higher pathologic grades of Barrett dysplasia.
    Anandasabapathy S; Jhamb J; Davila M; Wei C; Morris J; Bresalier R
    Cancer; 2007 Feb; 109(4):668-74. PubMed ID: 17211862
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting surveillance in Barrett's esophagus.
    Hillman L
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1311-2. PubMed ID: 18853989
    [No Abstract]   [Full Text] [Related]  

  • 29. [Esophagoscopic monitoring of Barrett's esophagus--additional life years of good quality or wasting of limited resources?].
    Voutilainen M
    Duodecim; 2010; 126(5):507-14. PubMed ID: 20597303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Localization of early-stage dysplastic Barrett's lesions in patients with short-segment Barrett's esophagus.
    Moriyama N; Amano Y; Okita K; Mishima Y; Ishihara S; Kinoshita Y
    Am J Gastroenterol; 2006 Nov; 101(11):2666-7. PubMed ID: 17090290
    [No Abstract]   [Full Text] [Related]  

  • 31. Does short-segment columnar-lined esophagus elongate during a mean follow-up period of 5.7 years?
    Manabe N; Haruma K; Imamura H; Kamada T; Kusunoki H; Inoue K; Shiotani A; Hata J
    Dig Endosc; 2011 Apr; 23(2):166-72. PubMed ID: 21429023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Veneto Region's Barrett's Oesophagus Registry: aims, methods, preliminary results.
    Zaninotto G; Minnei F; Guirroli E; Ceolin M; Battaglia G; Bellumat A; Betetto G; Bozzola L; Cassaro M; Cataudella G; Dal Bò N; Farinati F; Florea G; Furlanetto A; Galliani E; Germanà B; Guerini A; Macrì E; Marcon V; Mastropaolo G; Meggio A; Miori G; Morelli L; Murer B; Norberto L; Togni R; Valiante F; Rugge M
    Dig Liver Dis; 2007 Jan; 39(1):18-25. PubMed ID: 17141593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Barrett's esophagus: does the incidence of adenocarcinoma matter?
    Cameron AJ
    Am J Gastroenterol; 1997 Feb; 92(2):193-4. PubMed ID: 9040189
    [No Abstract]   [Full Text] [Related]  

  • 34. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management.
    Chennat J; Ross AS; Konda VJ; Lin S; Noffsinger A; Hart J; Waxman I
    Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improving screening practices for Barrett's esophagus.
    Shaheen NJ; Palmer LB
    Surg Oncol Clin N Am; 2009 Jul; 18(3):423-37. PubMed ID: 19500734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progress in outlining the frequency and risk of recurrent neoplasia after ablation of Barrett's esophagus.
    Peters JH
    Gastrointest Endosc; 2010 Apr; 71(4):704-5. PubMed ID: 20363412
    [No Abstract]   [Full Text] [Related]  

  • 37. Endoscopic resection for Barrett's esophagus with high-grade dysplasia or early esophageal adenocarcinoma.
    Watson TJ
    Semin Thorac Cardiovasc Surg; 2008; 20(4):310-9. PubMed ID: 19251170
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for esophageal cancer development.
    Falk GW
    Surg Oncol Clin N Am; 2009 Jul; 18(3):469-85. PubMed ID: 19500737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Barrett's esophagus at a tertiary care center: association of age on incidence and prevalence of dysplasia and adenocarcinoma.
    Guardino JM; Khandwala F; Lopez R; Wachsberger DM; Richter JE; Falk GW
    Am J Gastroenterol; 2006 Oct; 101(10):2187-93. PubMed ID: 17032182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The incidence of adenocarcinoma and squamous cell carcinoma of the esophagus: Barrett's esophagus makes a difference.
    van Blankenstein M; Looman CW; Hop WC; Bytzer P
    Am J Gastroenterol; 2005 Apr; 100(4):766-74. PubMed ID: 15784017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.